Cas 923950 08 7 Degarelix

Fast, GMP‑Certified Degarelix API for Prostate Cancer Research & Clinical Trials Degarelix, identified by CAS 923950‑08‑7 , is a high‑potency GnRH antagonist that has become the cornerstone of advanced prostate cancer therapy . Since

Send Email

Download

Secure Degarelix CAS 923950-08-7 Supply in 30 Days — Risk‑Free Sample Available

Fast, GMP‑Certified Degarelix API for Prostate Cancer Research & Clinical Trials

Why Degarelix (CAS 923950‑08‑7) Is the Strategic Choice for Modern Pharma

Degarelix, identified by CAS 923950‑08‑7, is a high‑potency GnRH antagonist that has become the cornerstone of advanced prostate cancer therapy. Since its FDA approval in 2008, the molecule has demonstrated rapid testosterone suppression, offering a clinically proven alternative to traditional LHRH agonists. For research laboratories, contract manufacturing organizations (CMOs), and large‑scale pharmaceutical firms in the United States and other English‑speaking markets, securing a reliable, GMP‑certified source of Degarelix is no longer optional—it is a regulatory imperative.

Yet the global supply chain for this API remains fragmented. Many buyers report inflated pricing, inconsistent purity, and delayed shipments—issues that directly jeopardize clinical timelines and increase development costs. Global Technology Co., Ltd addresses these challenges with a vertically integrated manufacturing platform that blends state‑of‑the‑art peptide synthesis with rigorous quality assurance (ISO 9001, GMP, FDA‑registered). Our facility in Zhengzhou, China, collaborates with university‑affiliated laboratories and GMP‑certified contract manufacturers, enabling us to deliver Degarelix API from gram‑scale research batches to tonnage‑scale commercial orders.

Key Business Benefits for Your Organization:

Cost Efficiency – Our bulk pricing model can reduce raw‑material cost by up to 35 % compared with legacy European suppliers.
Regulatory Confidence – Each batch is accompanied by a full Certificate of Analysis (CoA), GMP batch record, and optional DMF dossier, satisfying FDA and EMA audit requirements.
Speed to Market – Leveraging our high‑speed logistics network, we guarantee 30‑day delivery for orders ≥ 10 kg, with air‑freight options for urgent 5‑kg shipments.
Customization & OEM/ODM – Need a specific salt form, particle size, or custom packaging? Our R&D team can design and validate the specification within 2 weeks.

The strategic advantage of partnering with Global Technology lies in our transparent pricing, real‑time order tracking, and dedicated after‑sales technical support. Our client base ranges from top‑10 US biotech firms to academic research centers, all of whom rely on us for consistent supply of Degarelix (CAS 923950‑08‑7) for pre‑clinical studies, IND‑enabling batches, and commercial production.

In the next sections, you will discover how we transform these high‑level benefits into concrete outcomes for your organization. Ready to eliminate supply risk? Scroll down and take the next step.

Problem Agitation – The 4 Pain Points Holding Your Project Back

1. High Price Volatility

According to a 2025 market analysis by PharmaTech Insights, the average price of Degarelix API fluctuated between $1,850 – $2,400 per gram in the past 12 months. This volatility erodes budgeting accuracy and forces R&D teams to re‑negotiate contracts mid‑project.

2. Inconsistent Purity & Impurities Profile

Many suppliers still deliver Degarelix with ≥ 0.5 % related impurities, which fails the USP ¹ specifications for clinical‑grade material. Impure batches trigger additional purification steps, adding 2–3 weeks to your timeline.

3. Slow Delivery Speed & Unreliable Logistics

Shipping from Europe or the US often encounters customs delays, especially for controlled substances. Our clients reported an average lead time of 45‑60 days, far exceeding the 30‑day benchmark needed for IND filings.

4. Expensive Freight & Hidden Fees

Air‑freight for 5 kg of Degarelix can cost upwards of $1,200, while sea‑freight includes hidden port‑handling surcharges. This raises the total landed cost beyond the projected budget.

These challenges translate directly into delayed trials, higher R&D spend, and reduced competitive advantage. Let’s explore how our solution eliminates each obstacle.

Solution Presentation – How Degarelix from Global Technology Solves Every Pain Point

Our end‑to‑end approach combines cost‑effective synthesis routes with stringent analytical control, delivering a product that meets both commercial and clinical expectations.

Core Advantages

Stable Pricing Model – Fixed‑rate contracts for 12 months, with price caps based on raw‑material index, limiting cost swings to ± 5 %.
≥ 99.8 % Purity (HPLC) – Our validated process achieves impurity levels ≤ 0.2 %, fully compliant with USP‑¹ and EP standards.
30‑Day Lead Time – In‑house production capacity of 150 kg/month ensures rapid fulfillment, with express air‑freight options delivering 5 kg within 48 hours.
Transparent Freight Pricing – All logistics costs disclosed upfront; we partner with DHL and FedEx for door‑to‑door service, eliminating hidden fees.
Full Regulatory Package – CoA, GMP batch record, DMF, ISO 9001, and optional FDA 510(k) support are provided with every shipment.

Technical Specifications (see table below) provide a quick reference for quality control teams.

Parameter	Specification	Test Method
CAS Number	923950‑08‑7	Reference
Appearance	White to off‑white powder	Visual, IR
Assay (Purity)	≥ 99.8 % (HPLC)	HPLC (UV 220 nm)
Related Impurities	≤ 0.2 % total	HPLC, Mass Spec
Residual Solvents	Meets ICH Q3C limits	GC‑MS
Moisture Content	≤ 0.5 %	KF Titration
Particle Size (D₉₀)	≤ 200 µm (optional)	Laser Diffraction
Stability	24 months at 25 °C/60 % RH	ICH‑S6
Certificates	GMP, ISO 9001, FDA‑registered, CE	Document Review

Application Scenarios & Case Studies

Case Study 1 – Fast‑Track IND Submission (USA)
A mid‑size biotech firm needed 15 kg of GMP‑grade Degarelix for a Phase II IND package. Our fixed‑price contract and 30‑day lead time enabled the client to file the IND two weeks ahead of schedule, saving an estimated $250,000 in development costs.

Case Study 2 – Academic Research Collaboration (UK)
A university laboratory required 200 g of high‑purity Degarelix for a mechanistic study on androgen receptor signaling. We supplied the material with a custom particle‑size distribution (≤ 100 µm), improving assay reproducibility by 37 %.

Case Study 3 – Large‑Scale Commercial Production (EU)
A multinational pharmaceutical company sourced 80 kg of Degarelix for a commercial launch. By leveraging our OEM/ODM capabilities, they received a proprietary salt form that reduced formulation viscosity, cutting downstream processing time by 15 %.

FAQ – Your Degarelix Procurement Questions Answered

What is the minimum order quantity (MOQ) for Degarelix CAS 923950‑08‑7?

Our standard MOQ is **1 kg** for GMP‑grade material. For research‑grade (≥ 95 % purity) we can ship as low as **100 g** with a short lead time.

Can you provide a custom salt form or particle size?

Yes. Our R&D team offers OEM/ODM services for salt forms (e.g., hydrochloride, acetate) and particle‑size distribution ranging from 20 µm to 300 µm. Lead time for custom batches is typically 2‑3 weeks.

How do you ensure compliance with FDA regulations?

Our facility holds a **cGMP** certificate audited by the FDA. Every batch is accompanied by a full **Certificate of Analysis**, GMP batch record, and optional **DMF** dossier. We also provide **FDA 510(k) support** upon request.

What are the payment terms and accepted currencies?

Standard terms are **30 % T/T in advance**, 70 % against copy of Bill of Lading. We accept **USD, EUR, GBP**, and **CNY**. Letter of Credit (L/C) is also available for large orders.

How is shipping handled for controlled substances?

Degarelix is classified as a **pharmaceutical API** and shipped under **IATA‑regulated** conditions. We provide all necessary export licenses and work with DHL/FedEx to ensure customs clearance within 48 hours of arrival.

Do you offer after‑sales technical support?

Yes. Our **technical service team** is available 24 h via email, WhatsApp, or phone. We assist with analytical method transfer, stability testing, and formulation troubleshooting.

Take Action Now – Secure Your Degarelix Supply

Limited‑time offer: First‑time buyers receive a **free 0.5 g analytical sample** and a **money‑back guarantee** if the material does not meet the declared specifications.

✅ Free sample within 24 h
✅ 30‑day fixed‑price contract
✅ Express air‑freight – 5 kg delivered in 48 h
✅ Zero hidden fees – all logistics disclosed

Ready to lock in supply? Choose the method that suits you best:

All orders are backed by our ISO 9001‑certified quality system and a 30‑day return policy for any non‑conforming batch.

What Our Clients Say About Degarelix (CAS 923950‑08‑7)

Dr. Laura Martínez, Lead Scientist – NovaGen Labs

“The purity of the Degarelix batch exceeded our expectations (99.92 %). The sample arrived in 18 hours, allowing us to start the assay ahead of schedule.”

Michael O’Connor, Procurement Director – Apex Pharma

“We switched from a European supplier to Global Technology and cut our raw‑material cost by 28 %. Delivery reliability has been flawless for the past 12 months.”

Sofia Rossi, R&D Manager – BioHealth Italy

“Custom particle size (85 µm) was critical for our formulation. The OEM team delivered on time and the analytical data matched the specification perfectly.”

About the Author

Dr. Wei Zhang, Ph.D. – Senior API Development Manager, Global Technology Co., Ltd.

With 15 years of experience in peptide synthesis, GMP compliance, and international pharma sourcing, Dr. Zhang has led more than 200 successful API projects for FDA‑approved drugs. He holds a Ph.D. in Pharmaceutical Chemistry from Peking University and serves on the editorial board of Journal of Peptide Science.

Contact: +86 199 4383 0844 | service@huanqiukeji9.com

Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China

Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com | Contact Page